No Data
No Data
Part 2 of the stocks that moved the day before yesterday include Zain, Teraprope, Ise Chemical, etc.
Stock name <Code> 18th closing price ⇒ Compared to the previous day, Enya Fi HD < 2767 > 1648 -72. There is a sense of pause even in the rebound from last weekend. Appier Group < 4180 > 1224 -44. On the 17th, Tōkai Tokyo Securities lowered the target stock price. TOWA < 6315 > 10880 -340. Although the SOX index in the US has risen, the semiconductor sector is heavy. Raccoon HD < 3031 > 546 -14. There is a sense of exhaustion after the earnings report. H.I.S. <960>
Fujita Kan, landlord, Terapro, etc.
<4502> Takeda Pharmaceutical fell sharply by 123 to 4044. It was due to the selling material of the clinical phase 3 trial results of "Soticlestat", a drug being developed for refractory pediatric epilepsy, which were announced the day before. The drug was developed for "Dravet syndrome", which causes repeated seizures, and "Lennox-Gastaut syndrome", which causes weak spells, but it seems that both failed to achieve the main evaluation criteria. The performance impact associated with the current trial results, including impairment losses of intangible assets, will continue to be carefully evaluated.
Active and newly listed stocks during the morning session.
*Fujita Kanko<9722>, up 1000 points, due to restructuring concerns and upward revisions in Four Seasons' performance. *Akebono Brake Industry<7238>, up 20 points, expected to continue buying due to refinancing loan agreement. *Chijyu<3252>, up 257 points, newly rated as "1" by Daiwa Securities. *Nihon Denpa Kogyo<6779>, up 90 points, likely to benefit from the rise of electronic component stocks. *DOWA<5714>, up 416 points, towards group restructuring.
CyberLinks - significant rebound, announced the implementation of price adjustments for all services.
CyberLinKs <3683> rebounded significantly. It has announced a pricing revision for various services. The scheduled revision will take effect from October 2024, and covers all services in principle. The revision rate will increase by 10%, and for some services it is expected to increase by 20%. The background of this price revision is due to the changing business environment such as recent price hikes and chronic shortage of IT professionals. The move is seen as an effort to improve future profitability following the price revision.
Stocks with interesting potential based on volume changes, such as mono AI.
Stock Closing Price Change from Previous Day Volume*<4179> G-NEXT 311 46 1650500*<5240> mono AI 620 100 2783400*<2247> IFS&P500H Inv 16025 135 10643*<2246> French Govt Bond 7-10yr H Inv 762.9 87000*<1472> J400 Dub 277 4
Cyberlynx-- 1Q sales and profit increase, mobile network business showed strong performance
Cyberlinks <3683> announced consolidated financial results for the 1st quarter (January to March 24) of the fiscal year ending 2024/12 on the 14th. Net sales increased 2.3% from the same period last year to 4.311 billion yen, operating profit increased 6.0% to 355 million yen, ordinary profit increased 1.5% to 356 million yen, and quarterly net profit attributable to parent companies was 228 million yen (profit of 0.1 billion yen for the same period last year). Sales of the distribution cloud business increased 1.4% from the same period last year to 1,104 billion yen, segment profit (ordinary profit
No Data